Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Biotech under Barack

Nature Biotechnology volume 27, pages 237–244 (2009)Cite this article

The Obama administration looks to be a welcome shot in the arm for the scientific endeavor, but the current economic crisis is likely to keep several issues of key interest to biotech firmly on the back burner.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Funding for research and development in 2009 Economic Recovery Act Appropriations.

Author information

Authors and Affiliations

  1. Jeffrey L. Fox is a freelance writer based in Washington DC.,

    Jeffrey L Fox

Authors
  1. Jeffrey L Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fox, J. Biotech under Barack. Nat Biotechnol 27, 237–244 (2009). https://doi.org/10.1038/nbt0309-237

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0309-237

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing